Frank Holler

Mr. Frank A. Holler is an Independent Director at Rakovina Therapeutics, Inc., an Executive Chairman at Delivra Health Brands, Inc., a President & Chief Executive Officer at Ponderosa Capital, Inc. and a Chairman at PROOF Centre of Excellence.
He is on the Board of Directors at Rakovina Therapeutics, Inc. and PheroTech International, Inc. Mr. Holler was previously employed as a Chairman by Theratechnologies, Inc., an Executive Chairman by Sernova Corp., an Independent Director by Allon Therapeutics, Inc., a Chairman & Chief Executive Officer by BC Advantage Funds Ltd., a Co-Founder, Chairman & Chief Executive Officer by Lions Capital Corp., a Chief Executive Officer by Prime Trials Ltd., an Independent Director by Protox Therapeutics, Inc., an Independent Director by Xenon Pharmaceuticals, Inc., a President & Chief Executive Officer by ID Biomedical Corp., a Vice President-Investment Banking by Merrill Lynch Canada, Inc., a Vice President-Investment Banking by CIBC World Markets Corp.
(Old), a Chief Executive Officer by BC Advantage Funds Ltd., a Chairman by BIRC Corp., a Chairman by Emerillon Therapeutics, Inc., a Chairman & Chief Executive Officer by Lions Investment Management Ltd., and a Vice Chairman by Providence Health Care (Vancouver).
He also served on the board at Aquinox Pharmaceuticals, Inc., Contech Enterprises, Inc., Genome British Columbia, Angiotech Pharmaceuticals, Inc., British Columbia Biotechnology Association, LifeSciences British Columbia, CANTEST Ltd., In Motion Technology, Inc. and Redlen Technologies, Inc. He received his undergraduate degree from the University of British Columbia and an MBA from the University of British Columbia.